Company news

AREV NanoTec Brands Inc news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

CSE Bulletin: Delist - AREV Life Sciences Global Corp. (AREV)

March 31, 2025

AREV Announces Significant Corporate Progress Amid Trading Suspension

February 6, 2024

CSE Bulletin: Suspensions (AREV, EMER)

July 20, 2023

Notice Of Default - Update

July 10, 2023

Notice Of Default - Update

July 10, 2023

Notice of Default - Update

June 12, 2023

Notice of Default - Update

May 29, 2023

Notice of Default - Update

May 15, 2023

AREV Implements AI as a Driving Force to Identify Science Backed Compounds Synergistic to its Proprietary Extracts to Increase Efficacy of Traditional Medicine

May 9, 2023

AREV Terminates Private Placement and Term Sheet with Fiberlab, Inc.

March 27, 2023

AREV Signs Term Sheet with Fiberlab, Inc.

March 15, 2023

AREV Life Sciences Provides Annual Review for 2022 and Operational Update

February 28, 2023

Team from Queensland Brain Institute Identifies New Hericerin Derivitives from Lions Mane that Boost Nerve Growth and Enhances Memory

February 15, 2023

Arev Issues Incentive Stock Options

January 16, 2023

Arev Board Change

January 9, 2023

AREV Annual General Meeting Results

January 4, 2023

AREV Issues Shares for Debt

November 9, 2022

AREV's Issues Shares for Debt

November 8, 2022

Dr. Andrew Levinson Joins AREV Life Sciences Global Corporation Scientific Advisory Board

October 28, 2022

AREV Notes U.S. Governments $2.9 Billion Assistance to Address Food Insecurity

September 22, 2022

SUSTAINN, AREV's Ready to Use Therapeutic Foods discussed in leading article in HealthHIV

August 25, 2022

AREV Adds Dr. Apte to the SAB

August 17, 2022

AREV Corporate Update

August 17, 2022

AREV Corporate Update

August 10, 2022

AREV Life Sciences announces acceleration of the clinical development of SUSTAINN, as further predictions of global famine increase demand for Ready to Use Therapeutic Foods (RUTF)

June 15, 2022

AREV Life Sciences issues retention warrants

May 27, 2022

AREV Life Sciences enters Into Collaboration Agreement with Richardson Centre for Functional Foods and Nutraceuticals, University of Manitoba

March 10, 2022

AREV Life Sciences Completes Lab and Fungi Fruiting Room Build

February 23, 2022

AREV Life Sciences Advances Developments, New Appointments, and Relationships

February 17, 2022

AREV SAB member Richard Van Breeman PhD publishes landmark study on CoVid19

January 18, 2022

AREV Life Sciences appoints Allan Echino as Director and Denby Greenslade as interim CFO

December 23, 2021

AREV Life Sciences Settles Pending Litigation with Harvey

December 9, 2021

AREV Life Sciences / Absolem JV Receives Extraction Results

December 2, 2021

AREV Acquires Wright & Well Essentials Inc.

November 30, 2021

AREV Life Sciences Global Corp Announces Stock Option Grant

November 8, 2021

AREV Signs Definitive Collaborative Development Agreement with Voynich Biosciences and Invites Richard van Breemen PhD to SAB REVISED RELEASE first issued July 28, 2021

September 7, 2021

AREV Announces Brian Cameron as Chief Financial Officer

September 2, 2021

CSE Bulletin: Name Change - AREV Nanotech Brands Inc. (AREV)

August 10, 2021

AREV Changes their name to AREV Life Sciences Global Corp.

August 9, 2021

AREV Signs Definitive Collaborative Development Agreement with Voynich Biosciences and Invites Richard van Breemen PhD to SAB

July 29, 2021

Data Presented at the 11th IAS Conference on HIV Science Supports AREV's Development of SUS-TAINN(TM), a Ready-to-Use Therapeutic Food to Treat Global Malnutrition and Starvation

July 22, 2021

AREV Annual and Special General Meeting Results Appoints Mel Maxwell as an AREV Director

July 20, 2021

AREV Expands Operations to Rochester New York Establishing Wholly Owned U.S. Subisidary, AREV Life Sciences, Inc.

July 6, 2021

AREV Completes Land Survey and Soil Analysis for Cultivation of Mushrooms and Moringa and Prepares for Mass Production of Plant-Based Proteins for Use in Its Ready-To-Use Therapeutic Foods

June 16, 2021

AREV CEO Michael Withrow Buys 900,000 Shares of Company Stock

June 10, 2021

Germinator and AREV Nanotech Brands Inc. Sign Distribution Agreement to Provide the Genesis Platform of Surface Disinfection to Global Public Health Commodity Procurement Programs

June 3, 2021

AREV Engages Dr. Harold C. Smith to Join Scientific Advisory Board

June 2, 2021

AREV Life Sciences Expands its Extraction Results to Clinical Characterization of Compounds, Development of Advanced-Stage Therapeutic Foods and Discovery of Plant-Based Drugs

June 1, 2021

AREV Nanotec Brands Inc. Announces Management Cease Trade Order Revoked

June 1, 2021

AREV Nanotec Brands Inc. Provides Management Cease Trade Order Update

May 14, 2021

Older news releases →